Evidence map›Paper›PMID 38406612›Full record

ArticleJournal of clinical and experimental hepatology

Standard-Volume Is As Effective As High-Volume Plasma Exchange for Patients With Acute Liver Failure.

Anand V Kulkarni, Shantan Venishetty, Moiz Vora, Pragati Naik, Digvijay Chouhan, Sowmya Iyengar, Puja Karandikar, Anand Gupta, Amrit Gahra, Kalyan Rakam and 8 more

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical and experimental hepatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 1 institution in 1 country.

Anand V KulkarniDepartment of Hepatology, AIG Hospitals, Hyderabad, India.
Shantan VenishettyDepartment of Hepatology, AIG Hospitals, Hyderabad, India.
Moiz VoraDepartment of Hepatology, AIG Hospitals, Hyderabad, India.
Pragati NaikDepartment of Transfusion Medicine, AIG Hospitals, Hyderabad, India.
Digvijay ChouhanDepartment of Hepatology, AIG Hospitals, Hyderabad, India.
Sowmya IyengarDepartment of Hepatology, AIG Hospitals, Hyderabad, India.
Puja KarandikarDepartment of Critical Care Medicine, AIG Hospitals, Hyderabad, India.
Anand GuptaDepartment of Critical Care Medicine, AIG Hospitals, Hyderabad, India.
Amrit GahraDepartment of Hepatology, AIG Hospitals, Hyderabad, India.
Kalyan RakamDepartment of Critical Care Medicine, AIG Hospitals, Hyderabad, India.
Kumaraswamy ParthasarthyDepartment of Liver Transplantation Surgery, AIG Hospitals, Hyderabad, India.
Manasa AllaDepartment of Hepatology, AIG Hospitals, Hyderabad, India.
Mithun SharmaDepartment of Hepatology, AIG Hospitals, Hyderabad, India.
Sumana RamachandraDepartment of Liver Transplantation Surgery, AIG Hospitals, Hyderabad, India.
Balachandran MenonDepartment of Liver Transplantation Surgery, AIG Hospitals, Hyderabad, India.
Rajesh GuptaDepartment of Hepatology, AIG Hospitals, Hyderabad, India.
Nagaraja R PadakiDepartment of Hepatology, AIG Hospitals, Hyderabad, India.
Duvvu N ReddyDepartment of Hepatology, AIG Hospitals, Hyderabad, India.
CARE Hospitals · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/Aims: Acute liver failure (ALF) is associated with fatal outcomes without liver transplantation. Two randomized studies reported standard volume (SV) and high volume (HV) plasma exchange (PLEX) as effective therapeutic modalities for patients with ALF. However, no studies have compared the safety and efficacy of SV with HV PLEX, which we aimed to assess. Methods: This retrospective study included patients with ALF admitted between March 2021 and March 2023 who underwent PLEX. All patients underwent HV PLEX until May 2022, and then thereafter, SV PLEX was performed. The objectives of the study were to compare transplant-free survival (TFS) at 30 days, efficacy in reducing severity scores, biochemical variables, and adverse events between SV (total plasma volume x 1) and HV (total plasma volume x 1.5-2) PLEX. Results: Forty two ALF patients (median age: 23.5 years; females: 57.1%; MELD Na: 34.67 ± 6.07; SOFA score- 5.24 ± 1.42) underwent PLEX. Of these, 22 patients underwent SV-PLEX, and 20 underwent HV-PLEX. The mean age, sex, etiology distribution, and severity scores were similar between the groups. The median number of PLEX sessions (2) was similar in both groups. On Kaplan-Meier analysis, TFS was 45.5% in SV group and 45% in HV group ( Conclusions: SV PLEX is safe and as effective as HV PLEX in patients with ALF. Further randomized controlled trials with a larger sample size are needed to validate these findings.

Indexed as

liver failureliver transplantationMELD Naplasma exchange

Identifiers

PMID38406612
PMCPMC10885581
OpenAlexW4391431314

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.